Receptos
Fred Aslan (Founder)
Hugh Rosen (Founder)
Kristina Burow (Founder)
Summary
History
Receptos, Inc. was founded in April 2009. The company has since focused its research and development efforts on the treatment of immune diseases and cancer through targeting the sphingosine-1-phosphate (S1P) receptor modulators. Receptos’ clinical compounds target autoimmune diseases and inflammatory conditions, including multiple sclerosis and ulcerative colitis.
Mission
Vision
Key Team
Marcus F. Boehm (Founder)
Robert J. Peach (Founder)
Raymond E. Stevens (Founder)
William Rastetter (Founder)
Recognition and Awards
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Fred Aslan (Founder)
Hugh Rosen (Founder)
Kristina Burow (Founder)